Additional Products

aBSI

Learn more

aPROMISE

Learn more

Cardiolite®

(Kit for the Preparation of Technetium Tc99m Sestamibi for Injection)

Learn more

NEUROLITE®

(Kit for the Preparation of Technetium Tc 99m Bicisate for Injection)

Learn more

Xenon Xe-133 Gas

Learn more


Our Focus

Leveraging our strong heritage and expertise in radiopharmaceuticals, we are focused on delivering  innovative products to help Find, Fight and Follow disease in areas of high unmet need. We classify our products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics and Strategic Partnerships.

Our Radiopharmaceutical Oncology products help healthcare professionals Find, Fight and Follow cancer.

Our leading Precision Diagnostic agents assist healthcare professionals to Find and Follow diseases in the earliest stages—when it matters most.

As a partner of choice, Strategic Partnerships allow for us to collaborate with like-minded organizations across industry and academia to enable precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms.

References:
  1. Key Statistics for Prostate Cancer. American Cancer Society. Published January 19, 2024. Accessed May 21, 2024. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html#:~:text=Prostate%20cancer%20can%20be%20a,Survival%20Rates%20for%20Prostate%20Cancer
  2. Coronary Heart Disease. National Heart Lung and Blood Institute. Published December 20, 2023. Accessed May 21, 2024. https://www.nhlbi.nih.gov/health/coronary-heart-disease

Our Pipeline

Innovation is our continual search for a way to improve patients’ lives.